Please assess the completion status of the following clinical trial:

Trial Title: Effect of Furosemide on Confirmation of Ureteral Patency During Routine Cystoscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Undergoing any urogynecologic surgery~* No allergy or contraindication to receiving furosemide~* Normal Creatinine/glomerular filtration rate~Exclusion Criteria:~* Unable to consent, including if non English speaking~* Allergy or contraindication to receiving furosemide~* Intraoperative injury to the lower urinary tract

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- furosemide (Type: EXPERIMENTAL): furosemide 10mg (1mL) IV push for one dose
- placebo (Type: PLACEBO_COMPARATOR): normal saline 1mL IV push for one dose

Based on this trial design, predict the completion outcome and termination type (if applicable).